THE RENOPROTECTIVE EFFECT OF SODIUM-GLUCOSE COTRANSPORTER2 (SGLT2) INHIBITOR DAPAGLIFLOZIN IN TYPE 1 DIABETES

被引：0
|
作者：
Hodrea, Judit [1 ]
Lenart, Lilla [1 ]
Koszegi, Sandor [1 ]
Gellai, Renata [1 ]
Balogh, Dora B. [1 ]
Vannay, Adam [2 ]
Wagner, Laszlo J. [3 ]
Szabo, Attila J. [4 ]
Fekete, Andrea [1 ]
机构：
[1] Mta Se LendUlet Diabet Res Grp, Budapest, Hungary
[2] Mta Se Pediat & Nephrol Res Grp, Budapest, Hungary
[3] Semmelweis Univ, Dept Transplanat & Surg, H-1085 Budapest, Hungary
[4] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary
来源：
PEDIATRIC NEPHROLOGY | 2015年 / 30卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P - 216
引用
收藏
页码：1633 / 1634
页数：2
相关论文
共 50 条
  • [1] RENOPROTECTIVE EFFECT OF SGLT2 INHIBITOR DAPAGLIFLOZIN IN TYPE-1 DIABETES
    Balogh, Dora
    Hodrea, Judit
    Lenart, Lilla
    Hosszu, Adam
    Szkibinszkij, Edgar
    Vannay, Adam
    Wagner, Laszlo
    Szabo, Attila
    Fekete, Andrea
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [2] Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
    Paola Fioretto
    Andrea Giaccari
    Giorgio Sesti
    Cardiovascular Diabetology, 14
  • [3] Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
    Fioretto, Paola
    Giaccari, Andrea
    Sesti, Giorgio
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [4] The Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Dapagliflozin Causes Ketosis In Nondiabetic and Diabetic Mice
    Coch, Reilly
    Campbell, Jonathan
    D'Alessio, David A.
    DIABETES, 2017, 66 : A349 - A349
  • [5] Dapagliflozin: A new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes
    Vivian, Eva M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (05) : 361 - 372
  • [6] Diabetes Leads to Sodium-Glucose Cotransporter 2 (SGLT2) Increase in the Retina
    Leley, Sameer P.
    Luo, Qianyi
    Alex, Alpha L.
    Bhatwadekar, Ashay D.
    DIABETES, 2019, 68
  • [7] Dapagliflozin: A Novel Sodium-Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Shah, Niren K.
    Deeb, Wasim E.
    Choksi, Rushab
    Epstein, Benjamin J.
    PHARMACOTHERAPY, 2012, 32 (01): : 80 - 94
  • [8] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke
    Kimura, Genjiro
    CIRCULATION JOURNAL, 2017, 81 (06) : 898 - 898
  • [9] Role of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
    Lusk, Kathleen A.
    Barnes, Nicole E.
    US PHARMACIST, 2016, 41 (11) : 38 - 42
  • [10] Sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation and hepatocellular carcinoma prognosis
    Hendryx, Michael
    Dong, Yi
    Ndeke, Jonas M.
    Luo, Juhua
    PLOS ONE, 2022, 17 (09):
12345